The aims of treating juvenile idiopathic arthritis are to elicit treatment response toward
remission, while preventing future flares. Understanding patient and disease characteristics …

Aim Systemic juvenile idiopathic arthritis (sJIA) is a distinctive subtype of JIA characterized
by systemic features and poor outcome. We aimed to investigate demographic and clinical …

Background Children and adolescents with juvenile idiopathic arthritis (JIA) may suffer from
disability and disease-related damage. This study aimed to investigate the prevalence of …

Promising candidate tools for predicting disease severity and long-term remission in juvenile
arthritis are now available. These tools need external validation in other populations, and …

Objective To investigate medication prescription patterns among children with JIA, including
duration, sequence and reasons for medication discontinuation. Methods This study is a …

Objectives To evaluate the impact of family history of autoimmune diseases (FHADs) on the
clinical characteristics and outcome of juvenile idiopathic arthritis (JIA). Methods We …

Background Children with juvenile idiopathic arthritis (JIA) who achieve a drug free
remission often experience a flare of their disease requiring either intraarticular steroids …

Objective The aim of this study is to describe clinical features of patients with oligoarticular
juvenile idiopathic arthritis (JIA) who achieved inactive disease at 3rd month and also to …

Background: Systemic juvenile idiopathic arthritis (sJIA) is a diagnosis of exclusion. The
complex nature and clinical variety of the disease, as well as the vast clinical variation of …

Biologic and targeted synthetic DMARDs (b/tsDMARDs) have revolutionized the
management of multiple rheumatic inflammatory conditions. Among these, polyarticular JIA …